MindBio Therapeutics Overview
- Year Founded
-
2021
- Status
-
Public
- Employees
-
18
- Stock Symbol
-
MBIO
- Share Price
-
$0.06
- (As of Monday Closing)
MindBio Therapeutics General Information
Description
MindBio Therapeutics Corp is engaged in the research, development, and testing of psychedelic substances as potential treatments for a broad range of mental health conditions. The Company also invests in research to develop treatments for conditions such as depression, anxiety, PTSD, and chronic pain. Its segment mainly relates to pharmaceutical research and development activities. The Company operates in the Australasia region.
Contact Information
Website
www.mindbiotherapeutics.comCorporate Office
- Level 4, 91-97 William Street
- Melbourne, Victoria 3000
- Australia
Corporate Office
- Level 4, 91-97 William Street
- Melbourne, Victoria 3000
- Australia
MindBio Therapeutics Timeline
MindBio Therapeutics Stock Performance
As of 16-Nov-2026, MindBio Therapeutics’s stock price is $0.06. Its current market cap is $408K with 7.28M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.06 | $0.07 | $0.05 - $2.85 | $408K | 7.28M | 18.4K | -$3.73 |
MindBio Therapeutics Financials Summary
As of 31-Mar-2026, MindBio Therapeutics has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 31-Mar-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 | FY 2023 30-Jun-2023 |
|---|---|---|---|---|
| EV | 5,462 | 3,874 | 6,943 | 10,004 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (4,527) | (1,440) | (37) | (2,578) |
| Net Income | (4,702) | (1,816) | (269) | (2,882) |
| Total Assets | 814 | 76 | 130 | 445 |
| Total Debt | 1,533 | 1,463 | 3,326 | 3,291 |
MindBio Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
MindBio Therapeutics Comparisons
Industry
Financing
Details
MindBio Therapeutics Competitors (2)
One of MindBio Therapeutics’s 2 competitors is AtaiBeckley, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AtaiBeckley | Formerly VC-backed | New York, NY | ||||
| COMPASS Pathways | Formerly VC-backed | Altrincham, United Kingdom |
MindBio Therapeutics Patents
MindBio Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2026903997-A0 | Detection of neurologically active substances and fatigue in a human by analysis of voice characteristics | Pending | 28-Apr-2026 |
MindBio Therapeutics Signals
MindBio Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
MindBio Therapeutics FAQs
-
When was MindBio Therapeutics founded?
MindBio Therapeutics was founded in 2021.
-
Where is MindBio Therapeutics headquartered?
MindBio Therapeutics is headquartered in Melbourne, Australia.
-
What is the size of MindBio Therapeutics?
MindBio Therapeutics has 18 total employees.
-
What industry is MindBio Therapeutics in?
MindBio Therapeutics’s primary industry is Drug Discovery.
-
Is MindBio Therapeutics a private or public company?
MindBio Therapeutics is a Public company.
-
What is MindBio Therapeutics’s stock symbol?
The ticker symbol for MindBio Therapeutics is MBIO.
-
What is the current stock price of MindBio Therapeutics?
As of 16-Nov-2026 the stock price of MindBio Therapeutics is $0.06.
-
What is the current market cap of MindBio Therapeutics?
The current market capitalization of MindBio Therapeutics is $408K.
-
Who are MindBio Therapeutics’s competitors?
AtaiBeckley and COMPASS Pathways are competitors of MindBio Therapeutics.
-
What is MindBio Therapeutics’s annual earnings per share (EPS)?
MindBio Therapeutics’s EPS for 12 months was -$3.73.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process